Stockscreener 앱 받기
1.245
5.68%
-0.075
전일 마감가:
$1.32
열려 있는:
$1.29
하루 거래량:
1.13M
Relative Volume:
0.69
시가총액:
$74.39M
수익:
-
순이익/손실:
$-144.01M
주가수익비율:
-0.3105
EPS:
-4.01
순현금흐름:
$-113.02M
1주 성능:
-9.78%
1개월 성능:
-42.09%
6개월 성능:
-42.89%
1년 성능:
-85.92%
1일 변동 폭
$1.24
$1.32
1주일 범위
$1.24
$1.42
52주 변동 폭
$1.24
$9.34
바이오미아 퓨전 Stock (BMEA) Company Profile
명칭
Biomea Fusion Inc
전화
(650) 980-9099
주소
1599 INDUSTRIAL ROAD, SAN CARLOS
BMEA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.25 | 93.33M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.04 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.25 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.36 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.91 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
바이오미아 퓨전 Stock (BMEA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-28 | 개시 | Jefferies | Buy |
| 2025-06-03 | 재개 | Piper Sandler | Overweight |
| 2024-10-09 | 개시 | Edward Jones | Buy |
| 2024-09-27 | 업그레이드 | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | 업그레이드 | Truist | Hold → Buy |
| 2024-08-29 | 개시 | CapitalOne | Overweight |
| 2024-06-11 | 다운그레이드 | Truist | Buy → Hold |
| 2024-06-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-04-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-06 | 개시 | Truist | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-05-12 | 개시 | Barclays | Overweight |
| 2023-03-29 | 재확인 | Oppenheimer | Outperform |
| 2023-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2023-02-24 | 개시 | Citigroup | Buy |
| 2022-06-02 | 재개 | H.C. Wainwright | Buy |
| 2022-01-12 | 개시 | H.C. Wainwright | Buy |
| 2021-12-17 | 개시 | Oppenheimer | Outperform |
| 2021-05-11 | 개시 | JP Morgan | Overweight |
| 2021-05-11 | 개시 | Jefferies | Buy |
| 2021-05-11 | 개시 | Piper Sandler | Overweight |
모두보기
바이오미아 퓨전 주식(BMEA)의 최신 뉴스
Is Biomea Fusion Inc. a candidate for recovery play2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Top chart patterns to watch in Biomea Fusion Inc.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com
Long term hold vs stop loss in Biomea Fusion Inc.Share Buyback & Safe Swing Trade Setups - newser.com
Is Biomea Fusion Inc. stock a dividend growth opportunityJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
Is Biomea Fusion Inc. stock in correction or buying zoneMarket Movers & Verified Technical Signals - newser.com
Biomea Fusion Inc.’s volatility index tracking explained2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
Is Biomea Fusion Inc. stock trading at a premium valuationQuarterly Portfolio Summary & Weekly High Potential Alerts - newser.com
How risky is Biomea Fusion Inc. stock now2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Can Biomea Fusion Inc. stock rebound after recent weaknessAnalyst Downgrade & Pattern Based Trade Signal System - newser.com
Is Biomea Fusion Inc. stock dividend yield sustainable2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Can Biomea Fusion Inc. stock hit analyst price targetsEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Strategies to average down on Biomea Fusion Inc.Fed Meeting & Daily Risk Controlled Trade Plans - newser.com
Real time pattern detection on Biomea Fusion Inc. stockJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Can trapped investors hope for a rebound in Biomea Fusion Inc.Portfolio Value Report & Real-Time Volume Analysis Alerts - newser.com
Is Biomea Fusion Inc. trending in predictive chart modelsJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Is Biomea Fusion Inc. stock bottoming outMarket Activity Summary & Capital Protection Trade Alerts - newser.com
Biomea Fusion’s BMF-650: A New Hope in Obesity Treatment? - TipRanks
Why Biomea Fusion Inc. stock could be next big winnerWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Biomea Fusion’s BMF-219 Trial for Type 1 Diabetes: A Terminated Phase 2 Study - TipRanks
Cormorant Asset Management, LP Reduces Stake in Biomea Fusion Inc - GuruFocus
Biomea Fusion stock hits 52-week low at $3.58 amid sharp decline - MSN
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025 - Investing News Network
Biomea Fusion, Inc. to Present Preclinical Data for BMF-650 and Icovamenib at ObesityWeek® 2025 - Quiver Quantitative
Biomea (Nasdaq: BMEA) to present ObesityWeek posters on BMF-650 and icovamenib/semaglutide - Stock Titan
바이오미아 퓨전 (BMEA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):